Real clinical practice data: comparison of the efficacy and safety of apixaban and rivaroxaban in the treatment of VTE
Venous thromboembolic complications (VTEC), including deep vein thrombosis (DVT) and pulmonary embolism (PE), are common pathologies of the cardiovascular system. Between 20% and 28% of patients experience recurrent VTE within 5 years of initial diagnosis. International clinical guidelines for the t...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2022-05-01
|
| Series: | Евразийский Кардиологический Журнал |
| Online Access: | https://www.heartj.asia/jour/article/view/6331 |